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New Findings
 What is the topic of this review?
The topic of this review is how ion channels contribute to the physiology of the uterus, with
particular focus on novel potassium channels.
 What advances does it highlight?
Two families of potassium channels, encoded byKCNQ andKCNH genes, have been identified
as important players in the control of myometrial contraction and may represent interesting
novel therapeutic targets.
Ion channels play a key role in defining myometrial contractility. Modulation of ion channel
populations is proposed to underpin gestational changes in uterine contractility associated with
the transition fromuterine quiescence to active labour.Of themyriad ion channels present in the
uterus, this article will focus upon potassium channels encoded by theKCNQ genes and ether-a`-
go-go-related (ERG) genes. Voltage-gated potassium channels encoded by KCNQ and ERG
(termed Kv7 and Kv11, respectively) are accepted asmajor determinants of neuronal excitability
and the durationof the cardiac actionpotential.However, there is nowgrowing appreciation that
these ion channels have amajor functional impact in vascular and non-vascular smoothmuscle.
Moreover,Kv7 channelsmaybepotential therapeutic targets for the treatment of preterm labour.
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Introduction
The uterus is an incredibly complex organ that displays
considerable physiological plasticity, cellular remodelling
and robustness during pregnancy.However, perturbations
of the precise orchestrations that regulate the contractile
state of the uterus can have negative consequences for
the mother and fetus. Early activation of contractility
that, for example, results in spontaneous preterm birth
can be associated with a high risk of neonatal morbidity
and mortality, as well as lifelong ill health and socio-
economic consequences. Conversely, delayed delivery or
dysfunctional labour due to weak or poorly co-ordinated
contractions can lead to fetal hypoxia, clinical intervention
and a greater risk of postpartum haemorrhage.
If there are to be improvements in clinical management
and development of novel therapeutic strategies for
complicated pregnancies then a better understanding
of the mechanisms that determine normal and
pathophysiological uterine contractility is essential. There
aremany factors that dictate gestational changes in uterine
contractility, such as alterations in the steroid hormone
environment, inflammation and uterine stretch that is
exerted by the growing feto-placental unit. The impact
of these stimuli is a fine tuning of the mechanisms
controlling uterine smooth muscle contractility at the
cellular level, including gap junctions, G-protein-coupled
receptors, calcium regulatory proteins and contractile
filament interactions, but ultimately, all converge upon
a background electrical rhythm generated by the activity
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of ion channels, much like a good concerto relies on
the precise contributions from individual instruments in
an orchestra. Understanding the contribution of these
individual instruments to the uterine symphony is very
much awork in progress, but recent studies have identified
KCNQ and KCNH-encoded K+ channels as new and
functionally powerful elements that hold promise asmajor
regulatory mechanisms and potential therapeutic targets
for the treatment of intrapartum complications.
The purpose of this article is to provide a brief overview
of this field of research, with particular focus on two new
pieces of the puzzle rather than a comprehensive summary
of the many factors implicated in uterine physiology. The
reader is recommended to consult a number of more
comprehensive reviews for more depth in specific areas
(e.g. Taggart & Tribe, 2007; Wray, 2007).
Inherent excitability
Uterine smoothmuscle exhibits spontaneous contractility
that can be augmented by receptor agonists, such as
oxytocin (Wray, 2007). Spontaneous contractions are
intimately related to the generation of slow waves, upon
which action potentials are superimposed (Casteels &
Kuriyama, 1965; Kuriyama & Suzuki, 1976; Bengtsson
et al. 1984; Parkington et al. 1999). As gestation
proceeds towards labour, the resting membrane potential
of the uterine smooth muscle becomes progressively
more depolarized (Kuriyama & Suzuki, 1976; Bengtsson
et al. 1984; Parkington et al. 1999), and this is
associated with an increase in the force and frequency
of spontaneous contractions. The initiator of the
spontaneous activity, however, remains to be identified
unequivocally. In the gastrointestinal tract, peristalsis
is driven by multibranched, non-contractile cells that
express the c-kit receptor (termed interstitial cells of
Cajal or ICC). Similar ICC-like cells have been observed
in rodent and human myometrial tissue (Ciontea et al.
2005; Duquette et al. 2005; Allix et al. 2008). Moreover,
pharmacological blockade of the c-kit receptor with
imantanibordeletionof this genedoes affect the frequency
of contractions in the myometrium of mice. However, the
effects are subtle, and imantanib has negligible effect in
human myometrium, suggesting that the impact of ICC-
like cells is not as clearly defined in the uterus as it is in
the gastrointestinal tract. Irrespective of the genesis of the
spontaneous contractility, the operation of specific ion
channels maintains contractile activity, and elucidation
of the nature of the respective depolarizing (excitatory)
and hyperpolarizing (inhibitory) channels remains a key
challenge for uterine physiologists.
Excitatory pathways
In its simplest form, contraction of myometrium,
like that of all smooth muscle, is mediated by a
rise in [Ca2+] leading to activation of myosin light
chain kinase, and the subsequent phosphorylation of
myosin light chain at serine 19 allows actin–myosin
interaction (see Wray, 2007; Taggart & Tribe, 2007).
The rise in [Ca2+]i is mediated by an interplay between
increased Ca2+ influx through plasmalemmal channels,
Ca2+ release from the sarcoplasmic reticulum and Ca2+
sequestration processes. However, the major precipitatory
mechanism is the opening of L-type voltage-dependent
Ca2+ channels (VDCCs), as evidencedby themarkedeffect
of dihydropyridines, such as nifedipine, on myometrial
contraction (Sperelakis et al. 1992; Wray, 2007). There is
evidence that T-type VDCCs may also have some role in
maintaining spontaneous contractile activity (Taggart &
Tribe, 2007). In addition to VDCCs, voltage-gated sodium
channels have been recorded from isolated myometrial
smooth muscle (Sperelakis et al. 1992; Seda et al. 2007),
and the density of these currents increases in late
pregnancy. However, little is known about the molecular
nature of the sodium channels and how they contribute to
functional activity.
Membrane potential is key
If the influx of Ca2+ through VDCCs is a major
determinant of myometrial contractility then logically
the influence of membrane potential is central to this
mechanism (see Tong et al. 2011 for a computational
model). An important question, therefore, is what are the
principalmechanisms that propel themembrane potential
towards voltages that enhance VDCC open probability
and, conversely, which specific ion channels ensure
repolarization to more negative membrane potential
and closure of VDCCs? In most smooth muscle cells,
Ca2+-activated Cl− channels (CACCs) provide the major
depolarizing impetus, because smooth muscle cells
actively accumulate Cl− ions (Chipperfield & Harper,
2000). As a consequence, the activation of CACCs
leads to Cl− ion efflux sufficient to produce membrane
depolarization (Leblanc et al. 2005) and, subsequently,
to further activation of VDCCs. In relationship to uterine
smoothmuscle, Cl− currents due toCACC activation have
been recorded in rat myometrial cells, and inhibitors of
this channel, such as niflumic acid, attenuate myometrial
contractility (Jones et al. 2004), although these agents are
known to have pluripotent effects (Greenwood& Leblanc,
2007). Preliminary data also show that transcripts for
TMEM16A (Caputo et al. 2008; Schroeder et al. 2008; Yang
et al. 2008), the putativemolecular correlate of CACCs, are
present inmouse and humanmyometrium (AJ Davis, RM
Tribe & IA Greenwood, unpublished observations) as well
as in vascular smooth muscle cells (Davis et al. 2010). It is
worth noting that in the gastrointestinal tract, TMEM16A
is expressed by the ICCs, not the smooth muscle cells
(Hwang et al. 2009). A second mechanism to produce
C© 2013 The Authors. Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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membrane depolarization is to activate non-selective
cation channels, and various members of theORAI/STIM
and TRP gene family that encode for proteins associated
with store-operated and receptor-operated calcium entry
(see Wang et al. 2008 for overview) are present in rodent
and human myometrium (Dalrymple et al. 2002; Yang
et al. 2002; Babich et al. 2004). Non-selective cation
channels also have a degree of inherent Ca2+ permeability
that can potentially contribute to the general rise in [Ca2+]
and contraction.
Potassium channels: nature’s brakes
Co-ordinated contraction of the myometrium relies
on hyperpolarizing influences to limit the extent of
membrane depolarization (see Fig. 1) and subsequent
contraction. Consequently, potassium channels define the
magnitude, duration and periodicity of uterine electrical
events. Myometrium expresses a number of genes
encoding for different potassium channels, including
calcium-activated (BKCa; Anwer et al. 1993; Pe´rez et al.
1993), SKCa (Brown et al. 2007; Pierce et al. 2008),
acid-sensitive twin-pore channel TREK-1 (Bai et al.
2005; Buxton et al. 2010), inwardly rectifying ROMK1
(Lundgren et al. 1997) and various voltage-dependent K+
channels, especiallymembers of the Kv4 family (Song et al.
2001; Smith et al. 2007; Greenwood et al. 2009). In terms
of functional impact, inhibitors of BKCa, such as paxilline
or iberiotoxin, or blockers of SKCa, such as apamin,
have negligible effect on rodent or human myometrial
contractility (Aaronson et al. 2006; Brown et al. 2007;
Smith et al. 2007; Noble et al. 2010). In comparison,
the non-selective Kv inhibitor, 4-aminopyridine, enhances
contractility (Aaronson et al. 2006; Smith et al. 2007), and
the Kv4.2/4.3 blocker, phrixotoxin-2, induces contractions
in non-pregnant, but not pregnant, rat myometrium
(Smith et al. 2007). Set against this background, two novel
types of Kv channel encoded by members of the KCNQ
and KCNH gene families have been identified that appear
to act as key regulators of uterine contractility and offer
new therapeutic targets.
KCNQ- and ERG-encoded potassium channels
Ether-a`-go-go-related genes or ERGs (ERG1, 2 and 3)
are members of the KCNH gene family. All genes
encode for voltage-dependent K+ channels (Kv11.1–
11.3) that assemble as a tetramer to generate a Kv
channel with unique voltage-dependent properties due
to an over-riding c-type inactivation (Smith et al. 1996).
ERG1 (KCNH2) exists mainly as two splice variants
(ERG1a and 1b; London et al. 1997) and is expressed
predominantly in cardiac myocytes, where it contributes
to the late repolarizing phase of the cardiac action
potentials; mutations to the underlying gene underpin
a major component of hereditary arrhythmias. ERG2
and ERG3 are located in neurones and contribute to
the suppression of membrane excitability (Selyanko et al.
1999). The KCNQ gene family contains five members
Figure 1. Schematic representation of the functional role of potassium channels in uterine smooth
muscle contraction
Left-hand panel shows that open K+ channels result in membrane hyperpolarization that indirectly
limits the opening of voltage-dependent calcium channels shown in blue. This results in a less contracted
smooth muscle. In the right-hand panel, the potassium channels are non-functional due to blockade,
loss-of-function mutations or trafficking defects. This leads to membrane depolariziation, and the open
probability of the calcium channels increases. The concomitant influx of calcium contributes to smooth
muscle contraction.
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(KCNQ1–5), and each gene encodes a Kv channel
(Kv7.1–7.5, respectively) with low activation threshold
(V 0.5 ≈ −35mV) and minimal inactivation (Haitin &
Attali, 2008). Kv7 channels also exist as tetramers,
with Kv7.1 assembling homomerically. Kv7 activity is
modulated by local phosphoinositide levels (Hernandez
et al. 2008; Haitin & Attali, 2008), calmodulin and
association with auxiliary proteins encoded by the KCNE
gene family (McCrossan & Abbott, 2004). KCNQ genes
have a well-defined pattern of expression, with KCNQ1
located predominantly in the heart as well as the inner
ear; KCNQ2, 3 and 5 are mainly neuronal where they
comprise the so-called M-channel in neurones (Brown
& Adams, 1980; Selyanko et al. 2002); and KCNQ4 is
restricted to the inner ear and auditory nerves (Kharkovets
et al. 2000).Mutations toKCNQ genes underlie hereditary
arrhythmias (KCNQ1), epilepsy (KCNQ2/3) and deafness
(KCNQ4).
KCNQ- and ERG-encoded potassium channels and
smooth muscle
The impact of ERG- and KCNQ-encoded K+ channels
on cardiac and neuronal physiology was established over
10 years ago. However, both gene families have been
ascribed new roles of late through their identification as
key players in the regulation of smooth muscle activity.
Expression of KCNQ in smooth muscle was first
identified in rat stomach by Ohya et al. (2002a). Since
then, KCNQ transcripts have been identified in mouse,
rat and human blood vessels (e.g. Ohya et al. 2003; Yeung
et al. 2007; Makie et al. 2008; Ng et al. 2011), as well as in
the gastrointestinal tract, urinary tract and airways (see
Jepps et al. 2013 for comprehensive overview). KCNQ
channel blockers, such as linopirdine or XE991, evoke
contractions in the quiescent smooth muscles, such as
arteries, or enhance spontaneous contractility (e.g. Yeung
& Greenwood, 2005, Jepps et al. 2009, Rode et al. 2010;
Ipavec et al. 2011; Anderson et al. 2013). Serendipitously,
there are also activators of KCNQ-encoded channels, such
as the novel anticonvulsant retigabine, that relax smooth
muscles (see Jepps et al. 2013).
Expression of ERG has been determined in the
gastrointestinal tract (Akbarali et al. 1999; Ohya et al.
2002a; Farrelley et al. 2003; Parr et al. 2003), mouse portal
vein (Ohya et al. 2002b) and bovine epididymis (Mewe
et al. 2008), where the smooth muscles exhibit phasic
contractions. In these tissues, ERG channel blockers, such
as dofetilide or E4031, augment spontaneous contractions
tremendously and often cause individual events to fuse
into a tonic contraction.
In terms of the myometrium, all KCNQ isoforms are
expressed in non-pregnant mice, with KCNQ1 being
dominant, and the transcript level for all isoforms remains
stable throughout the oestrus cycle (McCallum et al.
2009). In pregnant mice, the expression of all KCNQ
genes drops dramatically at early stages of gestation but
recovers to robust levels by late stages (McCallum et al.
2011), suggesting that their main role is to regulate
contractility at the end of pregnancy rather than to induce
quiescence in early pregnancy. Transcripts for all KCNQ
genes except for KCNQ5 have also been detected in
myometrium from women undergoing Caesarean section
at term (McCallum et al. 2011). Of the three ERG
genes, only ERG1 is expressed in mouse (Greenwood
et al. 2009) and human myometrium (R.M. Tribe
& I. A. Greenwood, unpublished observations). In the
BALB/cmousemyometrium, both splice variants of ERG1
were detected, with the longer C-terminal ‘a’ isoform
dominant (Greenwood et al. 2009), and the expression
of this gene did not vary throughout mouse gestation
or following parturition (Greenwood et al. 2009). All
members of the KCNE gene family whose expression
products alter the membrane insertion capabilities and
biophysical properties of KCNQ- and ERG-encoded
channels (McCrossan & Abbott, 2004) are also expressed
in virgin and pregnant mouse myometrium (Greenwood
et al. 2009; McCallum et al. 2009). Moreover, transcripts
for KCNE2 and KCNE4 increased markedly in mouse
myometrium throughout pregnancy (Greenwood et al.
2009; McCallum et al. 2009), an observation that was
mirrored at the protein level (Greenwood et al. 2009).
A functional role for both KCNQ- and ERG-encoded
K+ channels has been determined in isometric tension
and single-cell electrophysiological studies. Linopirdine
and XE991 are specific inhibitors of all KCNQ channel
isoforms that increase contractile activity in either
non-pregnant or pregnant mouse myometrium, mainly
through an increase in the frequency of contractions
(McCallum et al. 2009, 2011). These agents have
similar effects on term non-labouring samples of
human myometrium (McCallum et al. 2011). In
line with a working hypothesis that increased K+
channel activity limits membrane depolarization and
suppresses voltage-dependent Ca2+ influx, the KCNQ-
encoded K+ channel activators, flupirtine and retigabine,
produce rapid inhibition of spontaneous and oxytocin-
driven contractility in mouse and human myometrium
(McCallum et al. 2009, 2011). This tocolytic activity is
more marked in myometrium from late pregnant mice
compared with early pregnant mice (McCallum et al.
2011).
Specific blockers of ERG-encoded channels, such as
dofetilide or E4031, have a more striking effect on
spontaneous contractility of mouse myometrium than
KCNQ channel blockers (mean integral of tension
increases by ∼300%, in comparison to ∼50% seen
with XE991) that is usually manifest as an increase in
the amplitude and duration of individual contractions
(Greenwood et al. 2009). Inhibitors of ERG-encoded
C© 2013 The Authors. Experimental Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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channels also have a dramatic effect on oxytocin-mediated
contractions in mouse myometrium, with tissues
often generating sustained contractions of considerable
magnitude (Greenwood et al. 2009). Activators of ERG-
encoded K+ channels (NS1643 or PD118057) also
attenuate contractions in mouse uterus. However, in
contrast to KCNQ channel modulators, the effects of
channel blockers and activators is lost in the final stages
of mouse pregnancy (Greenwood et al. 2009). This is
associated with an inability to record dofetilide-sensitive
K+ currents in isolated myometrial smooth muscle cells
that are present in cells from non-pregnant animals
(Greenwood et al. 2009). Modulators of ERG channels
become effective again in tissues harvested only 3 h after
delivery (Greenwood et al. 2009). Currently, the effects of
ERG inhibitors in human myometrial tissues have only
been studied in samples obtained from non-labouring
woman at term (end of pregnancy), so it is not yet
confirmed whether a similar molecular mechanism exists
in humans. However, this redundancy in the functional
impact of ERG-encoded channels in latemouse pregnancy
represents a potential pivot point in the switch from a
quiescent system to an excitable system able to generate
considerable rhythmic contraction in order to facilitate
fetal delivery.
Conclusion
The uterus remains an enigma. Despite much research,
there is still much to ascertain with regard to the
mechanisms that drive the switch from quiescence to
contractile activity preceding labour, and little is known
about the stimulus for induction of preterm labour.
Furthermore, existing therapies are far frombeing the ideal
tocolytics. The recent findings that KCNQ- and (ERG)
KCNH-encoded K+ channels have a major impact on
myometrial contractility and that the functional impact
of KCNH-encoded channels diminishes in an animal
model of term pregnancy represent progression towards
answering some of these questions.
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